Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT02743741
What this trial is testing

Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
University Health Network, Toronto 195
Very early researchLooking for participantsNCT06438250
What this trial is testing

68Ga-JH04 PET/CT: Dosimetry and Biodistribution Studies

Who this might be right for
Malignant Neoplasm
First Affiliated Hospital of Fujian Medical University 5
Early research (Phase 1)Study completedNCT02323893
What this trial is testing

Study of Kinetics, Dosimetry & Safety of [18F]F-AraG, a Positron Emission Tomography Imaging Tracer in Healthy Humans

Who this might be right for
Cancer
CellSight Technologies, Inc. 6
Early research (Phase 1)Looking for participantsNCT07117214
What this trial is testing

A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers

Who this might be right for
Breast NeoplasmsCarcinoma, Non-Small-Cell Lung
Novartis Pharmaceuticals 36
Early research (Phase 1)Ended earlyNCT05999292
What this trial is testing

Phase 1 Study of 68Ga-R8760

Who this might be right for
Adrenocortical Carcinoma
Radionetics Oncology 11
Early research (Phase 1)Study completedNCT01089998
What this trial is testing

PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations

Who this might be right for
Diagnostic Imaging
Lantheus Biosciences Ltd. 35
Early research (Phase 1)Looking for participantsNCT05283330
What this trial is testing

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Who this might be right for
Cervical CancerBreast CancerColon Cancer+4 more
Orano Med Theranostics, SAS 48
Early research (Phase 1)Study completedNCT00667537
What this trial is testing

PK in Pts With HRPC & Skeletal Metastes

Who this might be right for
Prostatic Neoplasms
Bayer 6
Testing effectiveness (Phase 2)UnknownNCT05506566
What this trial is testing

68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies

Who this might be right for
TumorPositron-Emission Tomography
First Affiliated Hospital of Fujian Medical University 50
Very early researchEnded earlyNCT01632696
What this trial is testing

Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors

Who this might be right for
Malignant Solid Tumor
Peregrine Pharmaceuticals 11
Not applicableLooking for participantsNCT06361784
What this trial is testing

Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location Matters. (LOCATION MATTERS)

Who this might be right for
Locally Advanced Lung Non-Small Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 150
Early research (Phase 1)Ended earlyNCT02052297
What this trial is testing

A Validation and Dosimetry Study of GSK2634673F PET Ligand

Who this might be right for
Idiopathic Pulmonary Fibrosis
GlaxoSmithKline 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT05214820
What this trial is testing

68Ga-PSMA PET Imaging of Upper Metastatic Gastric Cancers to Determine Eligibility to Endoradiotherapy

Who this might be right for
Upper Digestive Tract Cancer
Centre de recherche du Centre hospitalier universitaire de Sherbrooke 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06383052
What this trial is testing

177Lu-NYM032 Injection in mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Norroy Bioscience Co., LTD 30
Very early researchEnded earlyNCT01479348
What this trial is testing

Imaging Study for FdCyd and THU Cancer Treatment

Who this might be right for
Head and Neck NeoplasmsLung NeoplasmsUrinary Bladder Neoplasms+1 more
National Cancer Institute (NCI) 5
Not applicableEnded earlyNCT00178347
What this trial is testing

Radiation Dosimetry in Teeth

Who this might be right for
Radiation Tolerance
University of Rochester 10
Not applicableUnknownNCT05832385
What this trial is testing

Effects of Different Radiation Dosimetry for Anorectal Function of Patients With Pelvic Cancer

Who this might be right for
Anorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 124
Early research (Phase 1)Looking for participantsNCT07604116
What this trial is testing

Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA

Who this might be right for
Multiple System Atrophy (MSA)Parkinson's Disease (PD)
Synusight Biotech (Shanghai) Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT00458952
What this trial is testing

Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma

Who this might be right for
PheochromocytomaParaganglioma
Molecular Insight Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07056439
What this trial is testing

Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients

Who this might be right for
PET Imaging in Patients With Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 50
Next Page